IMPORTANCE Subungual melanoma in situ (SMIS) is a malignant neoplasm that requires early diagnosis and complete surgical excision; however, little is known about the usefulness of the detailed dermoscopic features of longitudinal melanonychia (LM) to predict the diagnosis of SMIS.
P atients with longitudinal melanonychia (LM) require clinical attention because of the potential for subungual melanoma (SUM) to appear as LM. 1 Histopathologic analysis of the nail matrix is the criterion for establishing a cause for LM; however, biopsy of the nail matrix must be performed cautiously because of the potential sequelae of severe pain and onychodystrophy. Dermoscopy, a noninvasive imaging modality, improves the diagnostic accuracy for various causes of LM, including SUM, lentigines, nail matrix nevi, and subungual hemorrhage.
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The clinical ABCDEF mnemonic was developed by Levit et al 11 to describe the clinical features and risk factors for the development of subungual melanoma. The ABCDEF mnemonic incorporates the following criteria: A, for age and Asian, African American, or Native American race/ethnicity; B, brownblack pigment, breadth of at least 3 mm, or blurred border; C, change in the nail band or lack of change subsequent to adequate treatment; D, digit affected or involving the dominant hand; E, extension of pigment onto the proximal or lateral nail folds; and F, family or personal history of melanoma or dysplastic nevus. The criteria are designed to assist clinicians in predicting the potential for malignant neoplasm while examining patients with LM. Limitations of the mnemonic include lack of validation in a clinical setting, the inclusion of clinical and demographic variables that may not be practical for the diagnosis of SUM, and the limited use among dermatologists in the United States (range of dermatologists, 12%-32%). 12 The optimal management of SUM includes early diagnosis and complete surgical excision. 13 Although dermoscopy is not a replacement for histopathologic diagnosis, 14,15 the detailed examination of magnified morphologic patterns of the nail unit may aid physicians in the detection of SUM. [16] [17] [18] [19] However, the detailed dermoscopic features of subungual melanoma in situ (SMIS) have not been sufficiently elucidated. 18 In this study, we investigated the characteristic dermoscopic findings of SMIS in comparison with those of benign LM. Furthermore, we propose a predictive scoring model for the diagnosis of SMIS based on the characteristic dermoscopic features of SMIS.
Methods
Cases of LM were retrospectively collected from Seoul National University Hospital in Seoul, South Korea, from September 1, 2013, to July 31, 2017. The cases of LM included in the study were determined as follows: (1) 
Analysis of Dermoscopic Findings
The dermoscopic features of SMIS were analyzed and compared with those of benign LM. Widths of pigmentation of at least 3 mm and at least 6 mm were used as cutoffs suggestive of a malignant origin of LM as was previously reported in the literature. 11, 20 Colors were classified as gray, light brown, dark brown, and black. The investigated dermoscopic patterns were defined as follows: (1) multicolor pigmentation (LM is composed of ≥2 colors); (2) asymmetry (drawing a midline along the longitudinal band results in colors and patterns that differ between the halves); (3) border fading (the borders of pigmentation are ill defined and the band shows gradual fading at the periphery); (4) triangular sign (wider pigmentation at the proximal aspect of the band compared with the distal aspect); (5) dots and globules (small, round to oval pigmentation); (6) the Hutchinson sign (periungual pigmentation of the nail fold or hyponychium); and (7) nail plate dystrophy. 21 All dermoscopic findings were independently evaluated by 2 of us (J.O. and J.-H.M.), and any disagreement was resolved by consensus.
Statistical Analysis
The sensitivity, specificity, and accuracy rates were calculated for each dermoscopic variable. Sensitivity was defined as the number of SMIS cases showing the dermoscopic finding divided by the total number of SMIS cases; specificity was defined as the number of benign LM cases without the dermoscopic finding divided by the total number of benign LM cases; and accuracy was defined as the number of SMIS cases with the dermoscopic finding plus the number of benign LM cases without the dermoscopic finding, with the sum divided by the total number of SMIS and benign LM cases. The Pearson χ 2 test or Fisher exact test (for <5 cells expected) and the unpaired, 2-tailed independent t test were used
Key Points
Question Can dermoscopy aid in the differentiation of subungual melanoma in situ from benign longitudinal melanonychia?
Findings In this cohort study of 45 patients with pigmented nails, asymmetry, border fading, multicolor pigmentation, width of the pigmentation of at least 3 mm, and presence of the Hutchinson sign were features associated with subungual melanoma in situ. A predictive scoring model incorporating these features was reliable for the detection of subungual melanoma in situ, with a sensitivity of 89% and a specificity of 62%.
Meaning A predictive scoring model for the detection of subungual melanoma in situ may assist clinicians in the examination of patients with adult-onset longitudinal melanonychia affecting a single digit.
to compare dermoscopic variables in cases of SMIS and benign LM. Two-sided P < .05 was considered statistically significant. Univariate logistic regression analysis was performed to calculate the odds ratio (OR) of statistically significant dermoscopic features predictive of SMIS compared with those of benign LM. A predictive scoring model for SMIS was established from the β coefficients derived from the logistic regression. The sensitivity and specificity of different cutoff values for the SMIS predictive scoring model were calculated and a receiver operating characteristic curve was generated. Interobserver agreement was represented by the Cohen's κ coefficient. All statistical analyses were performed using SPSS, version 22.0 (IBM Corporation).
Results
Of the total 45 patients with pigmented nails, 19 patients with SMIS included 14 women who had a mean (SD) age of 52.0 (14.4) years, and 26 patients with benign melanonychia included 18 women and had a mean (SD) age of 48.1 (13.2) years. Histopathologic analysis was performed in all cases of SMIS. Histopathologic examination was also conducted in 17 of the 26 cases of benign LM and revealed 1 case of nail matrix nevus and 16 cases of melanocytic activation of the nail matrix.
The mean follow-up duration of the 9 clinically diagnosed cases of benign LM was 24.04 months (range, 15.14-41.50 months).
Patient Demographics
There were no statistically significant differences in sex, age, duration of melanonychia, and affected digit between the SMIS and benign LM groups. A history of trauma was recalled in 3 of 19 cases of SMIS (16%) and 1 of 26 cases of benign LM (4%) ( Table 1) .
Comparative Analysis of Dermoscopic Findings
Mean (SD) pigmentation width was significantly broader in the SMIS cases than in the benign melanonychia cases (9. Figure 1 and Figure 2) . Asymmetry was the most commonly identified dermoscopic feature and was observed in 18 of 19 cases (95%) of SMIS and 9 of 26 cases (35%) of benign LM (OR, 34.00; 95% CI, 3.88-297.70; P = .001). Border fading was more commonly observed in the SMIS group than in the benign LM group (14 [74%] 
Scoring Model for the Diagnosis of SMIS
Based on the logistic regression analysis, the coefficients of each factor were used to develop a scoring model for predicting SMIS by incorporating the following 6 variables: width of pigmentation of at least 3 mm, width of pigmentation of at least 6 mm, multicolor pigmentation, asymmetry, border fading, and the Hutchinson sign ( Table 3) . The total scores range from 0 to 8, with points assigned as follows: 2 points each for asymmetry, the Hutchinson sign, and a width of pigmentation of at least 6 mm; 1 point each for border fading, multicolor pigmentation, and a width of pigmentation of at least 3 mm. The sensitivity and specificity rates for each cutoff score of the model are shown in the eTable in the Supplement. The cutoff value of 3 points coincided with a sensitivity of 89% and a specificity of 62%. The receiver operating characteristic curve for the model had an area under the curve (C statistic) of 0.91 (eFigure 1 in the Supplement).
Discussion
We found the clinical and dermoscopic features (width of pigmentation ≥3 mm, width of pigmentation ≥6 mm, multicolor pigmentation, asymmetry, border fading, and the Hutchinson sign) to be predictive of SMIS in adult-onset monodactyl melanonychia. Incorporating these findings, we developed a predictive scoring model for the diagnosis of SMIS with a C statistic of 0.91. Prior studies have described demographic and morphologic features (clinical and dermoscopic) associated with SUM. 7 11 ; however, large-scale studies on the strength of this association are lacking because of the rare nature of SUM. None of the 19 patients with SMIS in our study reported a family history of melanoma. Therefore, additional studies on the value of family history in the setting of SUM, including SMIS, are needed. Both SUM and benign LM may be associated with trauma. 7, 22 There was no significant difference in the frequency of patient-reported trauma between the SMIS and benign LM groups in our data set, with 3 cases (16%) of SMIS and 1 case (4%) of benign LM associated with a history of trauma. Sex and duration of symptoms along with age, affected digit, family history, and history of trauma did not differ between the SMIS and benign LM groups and were excluded from our predictive scoring model. Width of pigmentation is an important risk factor for SMIS. Previous studies suggested that either a width of pigmentation of at least 3 mm or at least 6 mm be used to distinguish malignant from benign causes of LM. 11, 20 However, the significance of these measures has not been fully established. In this study, the mean (SD) pigmentation width was larger in the SMIS group than in the benign LM group (9. 
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In addition, gray pigmentation was suggested to be associated with nail apparatus melanomas. 16 In this study of cases of SMIS, dark brown was the most common color (84%) followed by gray (68%). However, in benign cases of LM, gray (58%) was the most common color. The significant distinction between SMIS and benign LM was the presence of multicolor pigmentation (89%) for most SMIS lesions. Univariate analysis revealed multicolor pigmentation to be useful in differentiating SMIS from benign LM (OR, 11.59; 95% CI, 2.21-60.89). Asymmetry is used for the diagnosis of cutaneous melanomas 23 ; however, it has not been formally described in the evaluation of LM to establish the diagnosis of SMIS or SUM. In this study, we evaluated asymmetry by drawing a longitudinal midline to bisect the band of the nail plate and then we compared the patterns and colors of the 2 segments (Figure 1) . Asymmetry was associated with a higher OR for the diagnosis of SMIS than the diagnosis of benign LM (OR, 34.00; 95% CI, 3.88-297.70). The discrepant proliferation of atypical melanocytes in the different regions of the affected matrix could result in clinical or dermoscopic asymmetry of the nail plate pigmentation. In previous studies, an irregular pigmentation pattern was proposed as an important feature of SUM. 9, 19 However, an irregular pigmentation pattern may be difficult to appreciate because of its subjective attributes, resulting in low interobserver or intraobserver agreement. 15, 19 Evaluation for asymmetry by drawing a hypothetical longitudinal midline and by comparing the pattern and pigmentation of the bisected halves may be more straightforward than evaluation of an irregular pigmentation pattern. Therefore, we propose asymmetry as a valuable measure in determining the malignant potential of LM. We found border fading to be a useful characteristic in the diagnosis of SMIS. Border irregularity is already used in the clinical evaluation of pigmented lesions. 23 As the atypical melanocytes in SMIS infiltrate the adjacent nail unit, this radial growth may result in the clinical or dermoscopic appearance of a faded border. Border fading was associated with a higher OR for the diagnosis of SMIS compared with the diagnosis of benign LM (OR, 9.33; 95% CI, 2.37-36.70). The Hutchinson sign is an important clue to the diagnosis of SUM, 24 and this factor was reiterated in our data set. Although biopsy of the nail matrix is the criterion standard diagnostic approach for LM, physician and patient concerns regarding its invasiveness and potential for complications may limit its use. A screening model to assess the potential for SMIS could be used to initiate risk-benefit discussions on whether to proceed with a biopsy of the nail matrix. In this study, we propose an 8-point scoring model for distinguishing SMIS from benign LM by assessing the likelihood of a diagnosis of SMIS based on the presence of specific dermoscopic findings, including width of the pigmentation, asymmetry, the Hutchinson sign, multicolor pigmentation, and border fading. Cutoff scores of 0 to 2 demonstrated a 100% sensitivity for diagnosis of SMIS, with specificities ranging from 0 to 50% (eTable 1 in the Supplement). A cutoff point of 3 yielded a sensitivity of 89% and a specificity of 62%.
Based on the analysis of dermoscopic variables, we propose that the following dermoscopic features be checked in the evaluation of adult-onset LM affecting a single digit: (1) asymmetry: the bisected halves of the pigmentation band are asymmetric based on a hypothetical midline; (2) border fading: the borders of pigmentation are faded or ill defined; (3) pigmentation: the lesion displays multicolor pigmentation; (4) width: the width of the pigmented lesion is greater than or equal to 3 mm or 6 mm; and (5) the Hutchinson sign: the pigment extends to the periungual skin. This 5-item checklist, consisting entirely of morphologic features, may be practical for clinician use during nail examinations.
Strengths and Limitations
Our findings must be interpreted in the context of the study design and population. This study included only patients with adult-onset LM affecting a single digit. Thus, the scoring model is not valid for LM diagnosed in the pediatric population or LM involving multiple digits, such as drug-induced melanonychia or melanonychia associated with systemic disease. We included clinically diagnosed cases of benign LM in addition to histopathologically confirmed cases to minimize selection bias. In our institution, biopsies of the nail matrix are typically performed in patients with LM when there is clinical suspicion for malignancy. To avoid misclassification, we included only cases with patients clinically diagnosed with benign LM by our nail experts. The proposed model is based on morphologic features only. Nonmorphologic risk factors (such as a change in a pigmented lesion over time) also could be considered in a study. The number of SMIS cases was limited because of the relatively rare nature of this disease. Further validation of our scoring model is necessary using a large sample size. 
Conclusions
Our results showed distinctive dermoscopic patterns in SMIS that aided in the differentiation between benign LM and SMIS. These dermoscopic findings were incorporated into a predictive scoring model for the detection of SMIS. We suggest that clinicians use this predictive scoring model during physical examination to assist in screening for SMIS. By facilitating the early diagnosis of SUM and by assisting patients and physicians with decisions to pursue a biopsy of the nail matrix, this scoring model has the potential to improve the prognosis of SUM and to promote informed decision making regarding the management of LM. 
